The western media is awash with reports of contaminated imports from China. But little is said about India, considered the biggest foreign source of pharmaceuticals for the USA.
A just-published study by Sweden's Goteborg University shows that, whatever the quality of the drugs being shipped out of India, they are leaving behind a toxic mess.
On analyzing samples of effluents from a wastewater treatment plant serving about 90 bulk drug manufacturers in Patancheru near Hyderabad, capital of the southern Indian state of Andhra Pradesh, the study found concentration of antibiotics and other drugs at 100 to 30,000 times the levels considered safe.
Incidentally Patancheru is dubbed one of the 24 environmental hotspots in the country.
The high levels of several broad spectrum antibiotics found in the effluents raise concerns about resistance development, the Swedish report said and called for increased focus on the potential release of active pharmaceutical ingredients from production facilities in different regions in India.
Activists say that the poor quality of some foreign-made products is only half the story. “Before we ever see those products, manufacturing plants in the countries of origin can pose an even greater danger to human and ecological health,” they warn.
In a 2005 Stan Cox of Kansas had described the devastation of water, land and human health he had seen around Patancheru which has emerged as a major production site of generic drugs for the world market.